drugset
drugset / Trial / NCT00934674

Study Comparing Two Different Tablet Formulations Of Bosutinib

NCT00934674 ↗

Phase 1 Completed 30 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedCrossoverOpen-labelTreatment

Summary

This study is comparing 2 formulations of bosutinib in healthy subjects.

Timeline

Start
2009-07
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bosutinib Small molecule — —

Indications

No indication recorded.